Suppr超能文献

有下呼吸道疾病的脆弱早产儿发生呼吸衰竭和死亡。

Respiratory Failure and Death in Vulnerable Premature Children With Lower Respiratory Tract Illness.

机构信息

Fundación INFANT, Buenos Aires, Argentina.

Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

出版信息

J Infect Dis. 2020 Sep 1;222(7):1129-1137. doi: 10.1093/infdis/jiaa046.

Abstract

BACKGROUND

Efforts to better understand the risk factors associated with respiratory failure (RF) and fatal lower respiratory tract infection (LRTI) in premature children in developing countries are necessary to elaborate evidenced-based preventive interventions. We aim to characterize the burden of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) LRTI in premature children and determine risk factors for RF and fatal illness in a vulnerable population.

METHODS

This is a prospective, population-based, cross-sectional study. Subjects with severe LRTI were enrolled during respiratory season. Risk factors for RF and death in premature infants were investigated.

RESULTS

A total of 664 premature children participated. Infant's hospitalization rate due to LRTI was 82.6/1000 (95% confidence interval [CI], 68.6-96.7/1000). Infant's RSV and hMPV rates were 40.9/1000 (95% CI, 36.3-45.6/1000) and 6.6/1000 (95% CI, 3.9-9.2/1000), respectively. The RF rate was 8.2/1000 (95% CI, 4.9-11.5/1000). The LRTI mortality was 2.2/1000 (95% CI, 0.7-3.7/1000); for RSV, the rate was 0.8/1000 (95% CI, 0-1.7/1000) with a case-fatality ratio of 1.8%. Never breastfeeding, malnutrition, younger than 6 months, congenital heart disease, and lower hematocrit were risk factors for RF. Experiencing pneumonia, pneumothorax, sepsis, or apnea were clinical determinants of poor outcomes.

CONCLUSIONS

Premature children under 2 years old in vulnerable environments experience RF and death more often than term counterparts. Modifiable risk factors associated with poor outcomes should prompt evidence-based interventions.

摘要

背景

为了制定基于证据的预防干预措施,有必要深入了解发展中国家早产儿呼吸衰竭(RF)和致命下呼吸道感染(LRTI)的相关风险因素。我们旨在描述呼吸道合胞病毒(RSV)和人偏肺病毒(hMPV)LRTI 在早产儿中的负担,并确定弱势人群中 RF 和致命疾病的危险因素。

方法

这是一项前瞻性、基于人群的横断面研究。在呼吸道疾病高发季节,对患有严重 LRTI 的患儿进行了研究。对早产儿 RF 和死亡的危险因素进行了调查。

结果

共有 664 名早产儿参与了研究。因 LRTI 而住院的婴儿发生率为 82.6/1000(95%置信区间[CI],68.6-96.7/1000)。婴儿 RSV 和 hMPV 的发生率分别为 40.9/1000(95% CI,36.3-45.6/1000)和 6.6/1000(95% CI,3.9-9.2/1000)。RF 的发生率为 8.2/1000(95% CI,4.9-11.5/1000)。LRTI 的死亡率为 2.2/1000(95% CI,0.7-3.7/1000);RSV 的死亡率为 0.8/1000(95% CI,0-1.7/1000),病死率为 1.8%。从未母乳喂养、营养不良、年龄小于 6 个月、先天性心脏病和较低的血细胞比容是 RF 的危险因素。患有肺炎、气胸、败血症或呼吸暂停是不良结局的临床决定因素。

结论

在脆弱环境中,2 岁以下的早产儿经历 RF 和死亡的风险高于足月婴儿。与不良结局相关的可改变危险因素应促使采取基于证据的干预措施。

相似文献

引用本文的文献

10
The journey to a respiratory syncytial virus vaccine.呼吸道合胞病毒疫苗研发之旅。
Ann Allergy Asthma Immunol. 2020 Jul;125(1):36-46. doi: 10.1016/j.anai.2020.03.017. Epub 2020 Mar 23.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验